What Are Inflammatory Cells and Their Function?

Inflammatory cells are the immune cells your body sends to damaged or infected tissue to fight off threats and begin repairs. They include white blood cells like neutrophils, macrophages, mast cells, eosinophils, basophils, and certain lymphocytes, each with a specialized job that ranges from swallowing bacteria whole to coordinating a broader immune attack. The term “inflammatory cells” is not a single cell type but a functional label for any immune cell that participates in the inflammatory response, and the cast of characters involved is larger and more nuanced than most people realize.

The First Responders: Neutrophils

When you cut your finger or pick up a bacterial infection, neutrophils are typically the first immune cells to arrive. They are the most abundant white blood cells in your bloodstream and can reach an injury site within minutes. Once there, they attack invaders through several mechanisms. They can engulf and digest microbes directly through a process called phagocytosis. They can unleash a burst of toxic chemicals, including reactive oxygen species, to poison nearby pathogens. And they have a more dramatic trick: they can expel their own DNA and antimicrobial proteins into web-like structures that physically trap and kill bacteria.¹ These sticky nets, known as neutrophil extracellular traps (NETs), were discovered relatively recently and represent a form of self-sacrifice: the neutrophil often dies in the process of casting them.²

Neutrophils are effective but blunt instruments. They cause collateral damage to surrounding healthy tissue, which is part of why inflamed areas become red, swollen, and sore. Their lifespan is short, usually just hours to a day or two at the site of infection. After they finish their work or die trying, other cells arrive to clean up the mess they leave behind.

Macrophages and Their Two Faces

Macrophages are larger, longer-lived cells that play several roles during inflammation. Some already reside in your tissues before any injury occurs. These tissue-resident immune cells are distinct from the circulating white blood cells that rush in from the bloodstream; they are seeded during embryonic development and can renew themselves locally without needing replacement from bone marrow.³ Other macrophages develop from circulating precursor cells that migrate into tissue during an inflammatory episode.

What makes macrophages especially interesting is their ability to shift personality depending on the signals around them. In a simplified framework, they can take on a pro-inflammatory state (sometimes called M1-like) or an anti-inflammatory, repair-oriented state (M2-like).⁴ Early in an infection, macrophages tend to skew toward the M1 profile: they produce chemicals that amplify inflammation, kill pathogens, and recruit more immune cells. Later, as the threat is controlled, signals from the environment nudge them toward the M2 profile, where they suppress inflammation, promote blood vessel growth, and help rebuild damaged tissue. This is not a binary switch but a spectrum, and a single macrophage can shift along it as conditions change.

One of their most critical jobs during the wind-down of inflammation is cleaning up dead neutrophils. Neutrophils that have done their job undergo a controlled form of cell death, and macrophages engulf these spent cells in a cleanup process called efferocytosis. This cleanup is itself a powerful anti-inflammatory signal: swallowing dead neutrophils pushes macrophages further toward their repair-oriented state.⁵

Mast Cells and the Swelling You Can Feel

Mast cells sit in tissues throughout your body, especially near surfaces exposed to the outside world like skin, airways, and the lining of your gut. They are packed with granules full of histamine and other signaling chemicals. When triggered by an injury, an allergen, or certain inflammatory signals, mast cells release those granules in a burst called degranulation. Histamine is the chemical that makes blood vessels leaky and dilated, which is why inflamed tissue swells and turns red: fluid and immune cells are flooding out of the bloodstream and into the tissue.

Research has shown that prostaglandin E2, a lipid signal produced at sites of inflammation, can directly activate mast cells to release histamine through a specific receptor pathway, and that blocking this pathway in mice significantly reduced the swelling response.⁶ This is the same basic mechanism behind allergic reactions: if you have ever taken an antihistamine for hay fever, you were counteracting the very thing mast cells release to drive inflammation.

Eosinophils and Basophils

Eosinophils and basophils are less numerous in the blood than neutrophils, but they play specialized roles that other cells cannot easily fill. Eosinophils were historically recognized for their ability to fight parasitic worms. When parasitic larvae invade tissue, eosinophils release granules loaded with toxic proteins that damage the parasite’s outer layers.⁷ These granule proteins can kill parasites in a dose-dependent manner, meaning the more eosinophils concentrated around the worm, the more damage they inflict.⁸

In the modern world, particularly in industrialized countries where parasitic worm infections are uncommon, eosinophils are more often noticed when they malfunction. An elevated eosinophil count frequently shows up in allergic conditions like asthma and eczema, where these cells contribute to tissue damage by releasing their toxic cargo in the wrong context. They are potent but indiscriminate when activated inappropriately.

Basophils are the rarest circulating white blood cells, but they punch above their weight in certain types of inflammation. Like mast cells, they release histamine, but they also produce signaling molecules that steer the broader immune response toward a particular pattern of activity associated with allergy and parasite defense. Recent research has demonstrated that basophils can even migrate into lymphoid tissues and cooperate with other immune cells to promote this type of response.⁹ Their role was underappreciated for decades, partly because they are so hard to study due to their scarcity.

Dendritic Cells as Messengers

Dendritic cells occupy an unusual position in the inflammatory response. They are not there primarily to kill invaders themselves but to gather intelligence and relay it to the rest of the immune system. As sentinels stationed in skin, mucosal surfaces, and other barrier tissues, they capture fragments of pathogens, process them, and then physically migrate to lymph nodes to present that information to T cells.¹⁰ This migration and presentation step is what connects the fast, nonspecific innate immune response to the slower, highly targeted adaptive immune response.

Dendritic cells mature in response to a variety of stimuli they encounter at the site of inflammation, including molecular fragments from microbes, signals from other immune cells, and even immune complexes formed when antibodies bind to pathogens.¹¹ The combination of what they captured and what signals they received during their maturation determines which kind of T cell response they activate. In this way, dendritic cells act as editors of the immune response, shaping whether the body mounts a strong inflammatory attack, a gentle regulatory response, or something in between.

Lymphocytes That Drive and Sustain Inflammation

When people hear “lymphocytes,” they usually think of cells that handle targeted immunity, like making antibodies or killing virus-infected cells. But several lymphocyte subsets are deeply involved in inflammation itself. Natural killer (NK) cells, part of the innate immune system, are recruited to sites of viral infection where they destroy compromised cells and produce signaling molecules that amplify the local inflammatory response.¹²

Among T cells, the subset known as Th17 cells has received enormous attention for its role in inflammatory disease. These cells produce a signaling molecule called IL-17 that recruits neutrophils and sustains tissue inflammation. In infection, this is helpful: a strong Th17 response can contain fungal and bacterial invaders. But when Th17 activation becomes chronic or misdirected, it contributes to autoimmune conditions such as arthritis, multiple sclerosis, and psoriasis.¹³ Adding a layer of complexity, Th17 cells can transition into a different pro-inflammatory state resembling Th1 cells, and this transition has been shown to be necessary for driving inflammatory bowel disease in experimental models.¹⁴ The ability of Th17 cells to shapeshift makes them a moving target for therapies, but drugs that block IL-17 signaling have already reached the clinic for conditions like psoriasis and ankylosing spondylitis.

How Inflammation Resolves

Inflammation is supposed to be temporary. Once the threat is handled, a coordinated shutdown sequence begins. Neutrophils stop arriving, and the ones already present undergo programmed cell death. Macrophages then clear the debris, including the dead neutrophils, through efferocytosis. This cleanup is not passive; it actively generates anti-inflammatory and pro-repair signals. Specialized lipid mediators produced from omega-3 fatty acids, among other sources, help orchestrate this resolution phase, promoting a return to normal tissue function rather than ongoing damage.

In wound healing, the transition from inflammation to repair follows a predictable arc. After macrophages shift toward their anti-inflammatory profile, new blood vessels begin to form and granulation tissue fills the wound. Specialized contractile cells then remodel this tissue into scar.⁵ Every step depends on inflammatory cells behaving correctly at the right time and then stepping aside. When they fail to step aside, the result is chronic inflammation, which underlies a surprisingly wide range of diseases.

When Inflammatory Cells Turn Against You

Atherosclerosis, the progressive narrowing of arteries, is one of the clearest examples of inflammatory cells causing long-term harm. Far from being a simple plumbing problem of cholesterol deposits clogging pipes, atherosclerosis is fundamentally an inflammatory disease. It involves inflammatory cell recruitment to the artery wall, where macrophages gorge on accumulated lipids and become foam cells, and the resulting plaque grows through a cycle of inflammation, damage, and repair gone wrong.¹⁵ Dendritic cells, smooth muscle cells, and other immune cells all participate in plaque formation and progression.¹⁶

Autoimmune diseases represent another failure mode. In conditions like rheumatoid arthritis, lupus, and multiple sclerosis, the immune system attacks the body’s own tissues, leading to chronic inflammation and progressive damage.¹⁷ The underlying mechanisms include impaired deletion of self-reactive T cells, defective regulatory cells that would normally keep inflammation in check, and dysregulated signaling that tips the balance toward pro-inflammatory activity.¹⁸ In both atherosclerosis and autoimmunity, the inflammatory cells themselves are functioning as designed: they detect something they interpret as a threat and respond. The problem is that the “threat” is either a harmless lipid deposit or the body’s own proteins.

How Inflammatory Cells Fuel Themselves

One of the more surprising discoveries in recent immunology is that inflammatory cells radically change their metabolism when they activate. Instead of burning fuel efficiently through the normal oxygen-dependent energy pathway, activated immune cells shift toward a faster but less efficient process called glycolysis, even when plenty of oxygen is available.¹⁹ This trade-off makes sense when speed matters more than efficiency: glycolysis generates energy and the molecular building blocks for new proteins and DNA more quickly, which an immune cell needs when it is dividing rapidly or producing large quantities of inflammatory signaling molecules.

Pro-inflammatory macrophages, Th1 cells, and Th17 cells all share this metabolic shift toward high glycolysis and high lactate production.²⁰ This insight has opened a new field of research exploring whether targeting immune cell metabolism could be a way to dial inflammation up or down therapeutically. If you can starve an inflammatory cell of its preferred fuel source, you might be able to calm an overactive immune response without broadly suppressing immunity the way traditional drugs do.

What a Blood Test Can and Cannot Tell You

A standard complete blood count is the most common way inflammatory cells show up in clinical medicine. It tallies the total number and types of white blood cells circulating in your blood. A high neutrophil count typically points to bacterial infection or acute inflammation. An elevated eosinophil count suggests an allergic reaction or parasitic infection. Beyond simple cell counts, ratios derived from the same blood draw, like the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio, have been studied as markers for cardiovascular and metabolic diseases.²¹

These ratios give a rough snapshot of the balance between different arms of your immune system and have been explored as predictive tools in settings ranging from cardiovascular risk assessment to trauma outcomes.²² However, a blood count is a blunt instrument. It tells you how many inflammatory cells are circulating, not what they are doing in specific tissues or whether they are in an M1-like or M2-like state. More specialized tests, like tissue biopsies examined under a microscope or flow cytometry that identifies specific surface markers, are needed to understand what inflammatory cells are actually up to in a particular organ.

Inflammaging and the Elderly Immune System

As people age, a curious phenomenon occurs: the baseline level of inflammation in the body creeps upward even without infection or injury. This low-grade, chronic, sterile inflammation has been termed “inflammaging,” and it is thought to contribute to many age-related diseases, including cardiovascular disease and frailty. The potential drivers are varied and include increased gut permeability allowing bacterial products to leak into the bloodstream, changes in gut microbiota, accumulation of senescent cells that pump out inflammatory signals, and dysregulated immune cells that produce more pro-inflammatory molecules than they should.²³

In this context, the problem is not that inflammatory cells are responding to an acute insult. It is that the entire system has drifted toward a higher inflammatory set point. Macrophages in aging tissues tend to be more pro-inflammatory at baseline. The resolution mechanisms that would normally shut down inflammation become sluggish. And the adaptive immune system becomes less precise, sometimes attacking harmless targets. Understanding inflammaging has become a major focus in gerontology because it suggests that targeting chronic inflammation directly, rather than treating individual age-related diseases one by one, could have outsized benefits for healthspan. The challenge is doing so without compromising the acute inflammatory response you still need to fight infections and heal wounds.